Multi-modal AI models for intermediate- to high-risk localized prostate cancer
by NRG OncologyCredit: Pixabay/CC0 Public DomainNRG Oncology investigators analyzed clinical and digital histopathology data from five Phase III prostate cancer trials (NRG/RTOG 9202, 9408, 9413, 9910
Updated on: January 30,2024
11
Multi-modal AI models for intermediate- to high-risk localized prostate cancer
by NRG OncologyCredit: Pixabay/CC0 Public DomainNRG Oncology investigators analyzed clinical and digital histopathology data from five Phase III prostate cancer trials (NRG/RTOG 9202, 9408, 9413, 9910
Updated on:January 30,2024
11
